Sales growth and innovation signal steady outlook amid legal and market challenges
Bayer Crop Science reported a positive start to 2026, showing nearly 7% sales growth compared to last year, according to CEO Bill Anderson. This increase was supported by additional revenue from soybean licensing agreements.
When this one-time gain is excluded, the company’s core business still grew by 1.4%, mainly driven by strong performance in corn sales.
Despite this growth, Bayer noted expected declines in crop protection products. However, the company remains confident about its overall direction. Anderson stated that Bayer is satisfied with its early results and is on track to meet its 2026 goals.
"Overall, we're pleased with how our businesses started the year, and we're in a good position to confirm our 2026 outlook," said Anderson. "At the same time, it's early. We know that the world around us is volatile and we'll have to stay vigilant. So, we're focused on hitting our goals and delivering them to farmers."
Legal matters are a key focus for Bayer in 2026. The company is currently working through a class settlement agreement introduced earlier this year. Important deadlines for objections and approvals are expected in the coming months.
Additionally, Bayer recently presented its legal arguments before the U.S. Supreme Court regarding the need for clearer regulations in agriculture.
Bayer is also pushing for stronger regulatory support for American farmers. The company believes farmers need clear rules and access to safe and effective tools, especially during times of economic pressure. Anderson emphasized that agriculture must remain productive, affordable, and environmentally responsible.
Innovation remains a major focus area. Bayer introduced a new insecticide called Plenexos, designed to protect crops while reducing harm to beneficial insects like pollinators. This product uses very low doses and can precisely target pests, making it both efficient and sustainable.
Plenexos is already being used in South America, and Bayer aims to introduce it to U.S. farmers soon. However, ongoing legal risks and regulatory challenges could slow down their progress. Anderson warned that high legal costs may discourage companies from investing in new agricultural technologies.
Photo Credit: Bayer-logo